James Quigley
Stock Analyst at Goldman Sachs
(0.15)
# 4,231
Out of 4,339 analysts
321
Total ratings
37.3%
Success rate
-9.3%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 263.00 | $288.35 | -8.79% | 34 | May 6, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 105.00 → CHF 106.00 | $118.44 | -10.50% | 25 | Apr 29, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €232.00 → €230.00 | $233.00 | -1.29% | 29 | Apr 27, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 349.00 → CHF 346.00 | $331.20 | +4.47% | 25 | Apr 24, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €214.00 | $171.70 | +24.64% | 23 | Apr 23, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €54.00 → €55.00 | $37.82 | +45.43% | 58 | Apr 20, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €153.00 → €147.00 | $128.35 | +14.53% | 43 | Apr 16, 2026 | |
| NVO Novo Nordisk | Downgraded: Hold | $68 → $41 | $44.19 | -7.22% | 8 | Mar 3, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €90.00 → €89.00 | $76.32 | +16.61% | 9 | Jan 30, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 650.00 → CHF 670.00 | $491.50 | +36.32% | 21 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $52.60 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $150.80 | -21.75% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $828.50 | - | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $60 | $44.15 | +35.90% | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | $13,960.00 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €13.00 → €10.50 | $1.46 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €27.00 → €28.00 | $5.01 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 65.00 → CHF 64.00 | $79.70 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 38.00 → CHF 21.00 | $38.25 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €38.00 → €36.00 | $23.84 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $2.91 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €410.00 → €545.00 | $699.70 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | kr 1,950 → kr 2,235 | $1,723.63 | n/a | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $27.64 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $26.89 | n/a | 1 | Jun 20, 2018 |
Novo Nordisk A/S
May 6, 2026
Maintained: Hold
Price Target: kr 263.00
Current: $288.35
Upside: -8.79%
Novartis AG
Apr 29, 2026
Maintained: Sell
Price Target: CHF 105.00 → CHF 106.00
Current: $118.44
Upside: -10.50%
Sartorius Aktiengesellschaft
Apr 27, 2026
Maintained: Hold
Price Target: €232.00 → €230.00
Current: $233.00
Upside: -1.29%
Roche Holding AG
Apr 24, 2026
Maintained: Hold
Price Target: CHF 349.00 → CHF 346.00
Current: $331.20
Upside: +4.47%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €214.00
Current: $171.70
Upside: +24.64%
Bayer Aktiengesellschaft
Apr 20, 2026
Maintained: Buy
Price Target: €54.00 → €55.00
Current: $37.82
Upside: +45.43%
Merck KGaA
Apr 16, 2026
Maintained: Buy
Price Target: €153.00 → €147.00
Current: $128.35
Upside: +14.53%
Novo Nordisk
Mar 3, 2026
Downgraded: Hold
Price Target: $68 → $41
Current: $44.19
Upside: -7.22%
Sanofi
Jan 30, 2026
Maintained: Hold
Price Target: €90.00 → €89.00
Current: $76.32
Upside: +16.61%
Lonza Group AG
Jan 29, 2026
Maintained: Buy
Price Target: CHF 650.00 → CHF 670.00
Current: $491.50
Upside: +36.32%
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $52.60
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $150.80
Upside: -21.75%
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $828.50
Upside: -
Jul 3, 2025
Maintained: Hold
Price Target: $65 → $60
Current: $44.15
Upside: +35.90%
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: $13,960.00
Upside: n/a
Oct 10, 2023
Maintained: Hold
Price Target: €13.00 → €10.50
Current: $1.46
Upside: n/a
Sep 25, 2023
Maintained: Buy
Price Target: €27.00 → €28.00
Current: $5.01
Upside: n/a
Sep 25, 2023
Maintained: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: $79.70
Upside: n/a
Sep 25, 2023
Maintained: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: $38.25
Upside: n/a
Sep 5, 2023
Maintained: Hold
Price Target: €38.00 → €36.00
Current: $23.84
Upside: n/a
Aug 8, 2023
Maintained: Buy
Price Target: $16 → $15
Current: $2.91
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: €410.00 → €545.00
Current: $699.70
Upside: n/a
May 12, 2023
Initiated Coverage: Sell
Price Target: kr 1,950 → kr 2,235
Current: $1,723.63
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $27.64
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $26.89
Upside: n/a